Back to search

University of Ioannina

Μελέτη του ρόλου των ιστικών καλλικρεϊνών 7 και 14 στον καρκίνο του παχέος εντέρου

Abstract

dc:description

Colon or colorectal cancer constitutes the third leading cause of cancer death in menand women in the U.S.A. and it is generally one of the prevalent cancer types in westernindustrialized countries. Human tissue kallikreins (KLKs) form a subfamily of 15 secretedserine proteases, which are encoded by 15 structurally similar genes that colocalize intandem on chromosome 19q13. KLKs are localized primarily in the cytoplasm of glandularepithelia, from which they are secreted. A plethora of studies have shown that kallikreinexpression on the mRNA and/or protein levels is deregulated in cancer and it has beencorrelated with prognosis, so kallikrein proteases have been proposed as promising noveltumor biomarkers or as potential therapeutic targets.Human tissue kallikrein-related peptidase 7 (KLK7) is a secreted serine protease withchymotrypsin-like specificity. KLK7 gene transcription produces 4 alternative mRNA splicevariants that differ due to the absence of intermediate coding exons and the structure of5΄ and 3΄untranslated regions. The mature enzyme participates in the proteolytic cascadeof normal skin desquamation, as well as in epithelial to mesenchymal transition andcleavage of extracellular matrix components during cancer progression. KLK7 geneexpression has been correlated with unfavorable prognosis in breast, ovarian, cervical,brain and colon cancer, but with favorable prognosis in lung adenocarcinoma.Human tissue kallikrein-related peptidase 14 (KLK14) is a secreted serine proteasewith dual specificity, trypsin- and chymotrypsin-like. KLK14 gene is transcribed into a single mRNA transcript. Normally, KLK14 participates in proteolytic cascades duringdesquamation of the stratum corneum, together with KLK7, and semen liquefaction, aswell as in extracellular matrix protein degradation and cleavage of insulin-like growthfactor binding proteins (IGFBPs) during tumor growth, invasion and metastasis. KLK14gene expression has been correlated with poor prognosis in breast, ovarian and prostatecancer.The aim of the present thesis was the analysis and clinical evaluation of theexpression of KLKs 7 and 14 at the mRNA and protein levels in cancerous and noncancerouscolon tissues, the study of KLKs 7 and 14 mRNA transcript variants in coloncancer cell lines and tissues, as well as the investigation of their biological role in coloncancer.KLK7 and KLK14 mRNA expression was quantitatively assessed in cancer, normal andadenomatous colon tissues. There is significantly higher mRNA expression of KLK7 andKLK14 in cancer tissues than normal ones (p<0.001 and p=0.035, respectively), as well asin cancer tissues compared to adenomas (p<0.001 for both of them). mRNA expressionlevels of both genes have discriminatory value between cancer and adenoma tissues(AUC=0.669 for KLK7 and AUC=0.708 for KLK14, p<0.001 for both), with KLK14 obtaininggreater distinguishing power. Moreover, both genes were shown to be fairly co-expressedin all three types of colon tissues examined (normal rs=0,667, p<0,001, adenomasrs=0.373, p=0.001, carcinomas rs=0,478, p<0.001), thus their expression is deregulated incancer in a coordinated manner. High mRNA expression of KLK7 and KLK14 is statisticallysignificantly associated with positive nodal status (p=0.015 and p=0.019, respectively), aswell as more advanced TNM stage of the disease (p=0.004 and p=0.043, respectively).KLK14 high mRNA expression is significantly associated with shorter disease-free (DFS)and overall survival (OS) of cancer patients (p=0.003 και p=0.016, respectively), whereasKLK7 high mRNA expression is significantly associated only with shorter DFS (p=0.004).Therefore, KLK7 and KLK14 gene expression could be regarded as candidate markers ofunfavorable prognosis for colon cancer patients, nevertheless not independent.KLK7 and KLK14 protease expression was immunohistochemically evaluated inparaffin-embedded colon cancer, adenoma and normal tissues. Localization pattern ofKLK7 and KLK14 proteins is primarily similar in all three types of tissue examined. There is no immunostaining in normal epithelial cells for none of the two KLKs, except for someslight KLK14 immunostaining observed in stromal cells. Βoth proteases are intenselyexpressed in neoplastic glandular epithelia, adenomatous or cancerous, especiallytowards the luminal surface and in the secretions, which confirms their secretory nature.Their cellular localization is cytoplasmic, homogeneous for KLK7 but granular for KLK14.Survival analysis demonstrated that KLK7 expression is a significant independent indicatorof poor prognosis for DFS (p=0.02) and marginally for OS (p=0.054) of colon cancerpatients, whereas KLK14 expression was not found to be associated with survival time.KLK7 and KLK14 mRNA transcript variants were detected in colon cancer cells lines(HT-29, HCT 116, DLD-1, Caco2, LS 180) and cDNA pools from tissues classified accordingto histological type. KLK7 splice variants 1, 2 and 3 are expressed in cell lines and cDNApools, whereas KLK7 variant 4 was not detected. KLK7 splice variants 1 and 2, whichproduce the same functional protein isoform, showed increased expression in adenomasand cancer. On the contrary, KLK7 splice variant 3, which produces a protein withoutserine protease activity, showed its higher expression in normal tissues and a gradualdecrease and loss during the course of the disease, possibly exhibiting a physiologicalregulatory role. The single KLK14 mRNA transcript is intensely expressed in cell lines,except Caco2, in which it was slightly detected. KLK14 mRNA transcript showed its higherexpression in adenoma cDNA pool, while in the following stages of the disease it was notintensely increased compared to normal tissue. This transcript may play a role in the earlytumorigenesis. In cell lines, except Caco2, and in certain cDNA pools, a new shorter thanthe classical KLK14 mRNA isoform was detected, lacking the intermediate coding exon 5.KLK7 gene expression silencing with the use of small interfering RNAs (siRNAs)resulted in a 50% decrease of the invasive capacity of HCT 116 colon cancer cells toinfiltrate GFR MatrigelTM membrane (p=0.016). Likewise, KLK14 gene expression silencingwith siRNAs resulted in a particularly high 80% decrease of the invasive capacity of DLD-1colon cancer cells to infiltrate GFR MatrigelTM membrane (p=0.006). Therefore, KLK7 andKLK14 expression is associated with the invasive capacity of colon cancer cells in vitro byenhancing their metastatic phenotype, but without any impact on their proliferativeability. KLK7 gene silencing with siRNAs altered the protein profile of HCT 116.colon cancercells, as demonstrated by Proteomic analysis. Among proteins with very significant(p<0.01) decreased expression after KLK7 knockdown, were two members of the heatshock protein family, HSP90B1 and HSPA4, which are implicated in cellular stressresponse, as well as the transcription co-factoy TRIM28. On the other hand, majorincrease was observed in the expression of anti-apoptotic protein ANP32B and twomembers of the annexin protein family, ANXA1 and ANXA3, which are deregulated incancer and have been correlated with tumor growth, invasion and metastasis.In conclusion, kallikrein-related peptidases 7 and 14 are significantly upregulated incolon adenomas and cancer, their expression is coordinately altered during the course ofthe disease and correlated with advanced TNM stage and nodal invasion, as well as withpatients’ survival time. They can contribute to prognosis, but not as independent factors.They are localized in the cytoplasm of epithelial cells of adenomas and adenocarcinomasfrom which they are secreted and their over-expression significantly enhances theinvasive and metastatic potential of cancer cells.

Degree

thesis:*
Grantor dc:publisher
University of Ioannina
Year dc:date
2014

Author and committee

dc:creator, dc:contributor.*
Authors dc:creator
  • Devetzi, Marina
  • Δεβετζή, Μαρίνα

Subjects

dc:subject × 8

Rights

Language dc:language
gre

Identifiers

dc:identifier.*
Identifier
10.12681/eadd/40235

Chain of custody

source
Harvested from
Greek National Archive of PhD Theses
Base URL
phdtheses.ekt.gr/eadd_oai/request
Last updated
2026-11-18
Source record
OAI-PMH GetRecord
citation

Devetzi, Marina; Δεβετζή, Μαρίνα. Μελέτη του ρόλου των ιστικών καλλικρεϊνών 7 και 14 στον καρκίνο του παχέος εντέρου. University of Ioannina, 2014. http://hdl.handle.net/10442/hedi/40235